iRhythm Technologies, Inc.
US ˙ NasdaqGS ˙ US4500561067

Introduction

This page provides a comprehensive analysis of the known insider trading history of Vijay K Lathi. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Vijay K Lathi has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:HARP / Harpoon Therapeutics, Inc. Director, 10% Owner 0
US:ITRM / Iterum Therapeutics plc 10% Owner 0
US:IRTC / iRhythm Technologies, Inc. Director 0
US:MEIP / MEI Pharma, Inc. 10% Owner 0
US:VSAR / Versartis, Inc.. 10% Owner 2,409,374
US:DRTX / Durata Therapeutics Inc 10% Owner 0
US:CMRX / Chimerix, Inc. 10% Owner 1,543,394
US:CNCE / Concert Pharmaceuticals Inc 10% Owner 0
Director, 10% Owner 1,377,497
US:RLYP / Relypsa, Inc. 0
10% Owner 0
US:TSPT / 10% Owner 1,636,982
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Vijay K Lathi. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases IRTC / iRhythm Technologies, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in IRTC / iRhythm Technologies, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

IRTC / iRhythm Technologies, Inc. Insider Trades
Insider Sales IRTC / iRhythm Technologies, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in IRTC / iRhythm Technologies, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2018-03-09 IRTC Lathi Vijay K 84,380 66.3969 84,380 66.3969 5,602,570 47 57.89 -717,812 -12.81
2018-03-08 IRTC Lathi Vijay K 26,979 66.5004 26,979 66.5004 1,794,114
2018-03-08 IRTC Lathi Vijay K 2,659 67.1704 2,659 67.1704 178,606
2018-02-22 IRTC Lathi Vijay K 45,723 65.6133 45,723 65.6133 3,000,037
2018-02-21 IRTC Lathi Vijay K 44,000 64.1162 44,000 64.1162 2,821,113
2018-02-20 IRTC Lathi Vijay K 125,000 61.8091 125,000 61.8091 7,726,138
2017-12-07 IRTC Lathi Vijay K 6,354 52.1495 6,354 52.1495 331,358
2017-12-07 IRTC Lathi Vijay K 72,000 52.7846 72,000 52.7846 3,800,491
2017-12-06 IRTC Lathi Vijay K 14,216 52.2855 14,216 52.2855 743,291
2017-12-05 IRTC Lathi Vijay K 57,430 52.4082 57,430 52.4082 3,009,803
2017-11-17 IRTC Lathi Vijay K 125,000 52.1102 125,000 52.1102 6,513,775
2017-11-16 IRTC Lathi Vijay K 100,000 52.0866 100,000 52.0866 5,208,660
2017-09-13 IRTC Lathi Vijay K 10 45.8240 10 45.8240 458
2017-09-13 IRTC Lathi Vijay K 34,603 49.5090 34,603 49.5090 1,713,160
2017-06-08 IRTC Lathi Vijay K 292,000 38.0400 292,000 38.0400 11,107,680
2017-06-06 IRTC Lathi Vijay K 138,624 36.6300 138,624 36.6300 5,077,797
2017-05-16 IRTC Lathi Vijay K 80,000 36.2600 80,000 36.2600 2,900,800
2017-05-16 IRTC Lathi Vijay K 130,000 35.2500 130,000 35.2500 4,582,500
2017-05-15 IRTC Lathi Vijay K 235,000 34.2500 235,000 34.2500 8,048,750
2017-05-12 IRTC Lathi Vijay K 200,000 34.2500 200,000 34.2500 6,850,000

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

IRTC / iRhythm Technologies, Inc. Insider Trades
Insider Purchases LITS / Lite Strategy, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in IRTC / iRhythm Technologies, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

LITS / Lite Strategy, Inc. Insider Trades
Insider Sales LITS / Lite Strategy, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in IRTC / iRhythm Technologies, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2015-03-24 MEIP New Leaf Ventures II, L.P. 1,601,390 1.9734 80,070 39.4680 3,160,183 323 404 29,187,693 923.61
2014-12-09 MEIP New Leaf Ventures II, L.P. 70,081 6.0085 3,504 120.1700 421,082
2014-12-08 MEIP New Leaf Ventures II, L.P. 9,004 6.0523 450 121.0460 54,495
2013-11-21 MEIP New Leaf Ventures II, L.P. 365,000 8.2500 18,250 165.0000 3,011,250
2013-05-08 MEIP New Leaf Ventures II, L.P. 100,000 8.4500 5,000 169.0000 845,000
2013-05-06 MEIP New Leaf Ventures II, L.P. 100,000 8.7000 5,000 174.0000 870,000
2013-04-19 MEIP New Leaf Ventures II, L.P. 157,300 8.4300 7,865 168.6000 1,326,039
2013-04-18 MEIP New Leaf Ventures II, L.P. 100,000 8.5700 5,000 171.4000 857,000
2013-02-19 MEIP New Leaf Ventures II, L.P. 300,000 6.8000 15,000 136.0000 2,040,000
2013-02-15 MEIP New Leaf Ventures II, L.P. 197,225 6.6000 9,861 132.0000 1,301,685

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

LITS / Lite Strategy, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Vijay K Lathi as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2024-03-11 2024-03-11 4 HARP Harpoon Therapeutics, Inc.
8.000% Series A Redeemable Preferred Stock
D - Sale to Issuer -10,000 0 -100.00
2024-03-11 2024-03-11 4 HARP Harpoon Therapeutics, Inc.
Common Stock
D - Sale to Issuer -395,783 0 -100.00
2024-03-11 2024-03-11 4 HARP Harpoon Therapeutics, Inc.
Common Stock
D - Sale to Issuer -1,463,386 0 -100.00
2023-10-27 2023-10-25 4 HARP Harpoon Therapeutics, Inc.
Common Stock
P - Purchase 171,500 395,783 76.47
2023-10-27 2023-10-25 4 HARP Harpoon Therapeutics, Inc.
Common Stock
P - Purchase 1,372,000 1,463,386 1,501.32
2023-03-27 3 HARP Harpoon Therapeutics, Inc.
8.000% Series A Redeemable Preferred Stock
10,000
2023-03-27 3 HARP Harpoon Therapeutics, Inc.
Common Stock
913,860
2023-03-27 3 HARP Harpoon Therapeutics, Inc.
Common Stock
2,242,839
2018-05-31 2018-05-30 4 ITRM Iterum Therapeutics plc
Series B-2 Preferred Shares
C - Conversion -148,603 0 -100.00
2018-05-31 2018-05-30 4 ITRM Iterum Therapeutics plc
Series B-1 Preferred Shares
C - Conversion -178,230 0 -100.00
2018-05-31 2018-05-30 4 ITRM Iterum Therapeutics plc
Series A Preferred Shares
C - Conversion -466,793 0 -100.00
2018-05-31 2018-05-30 4 ITRM Iterum Therapeutics plc
Ordinary Shares
P - Purchase 384,615 384,615 13.00 4,999,995 4,999,995
2018-05-31 2018-05-30 4 ITRM Iterum Therapeutics plc
Ordinary Shares
P - Purchase 278,062 1,071,688 35.04 13.00 3,614,806 13,931,944
2018-05-31 2018-05-30 4 ITRM Iterum Therapeutics plc
Ordinary Shares
C - Conversion 148,603 793,626 23.04
2018-05-31 2018-05-30 4 ITRM Iterum Therapeutics plc
Ordinary Shares
C - Conversion 178,230 645,023 38.18
2018-05-31 2018-05-30 4 ITRM Iterum Therapeutics plc
Ordinary Shares
C - Conversion 466,793 466,793
2018-03-12 2018-03-09 4 IRTC iRhythm Technologies, Inc.
Common Stock
S - Sale -84,380 0 -100.00 66.40 -5,602,570
2018-03-12 2018-03-08 4 IRTC iRhythm Technologies, Inc.
Common Stock
S - Sale -2,659 84,380 -3.05 67.17 -178,606 5,667,838
2018-03-12 2018-03-08 4 IRTC iRhythm Technologies, Inc.
Common Stock
S - Sale -26,979 87,039 -23.66 66.50 -1,794,114 5,788,128
2018-02-26 2018-02-22 4 IRTC iRhythm Technologies, Inc.
Common Stock
S - Sale -45,723 114,018 -28.62 65.61 -3,000,037 7,481,097
2018-02-22 2018-02-21 4 IRTC iRhythm Technologies, Inc.
Common Stock
S - Sale -44,000 159,741 -21.60 64.12 -2,821,113 10,241,986
2018-02-22 2018-02-20 4 IRTC iRhythm Technologies, Inc.
Common Stock
S - Sale -125,000 203,741 -38.02 61.81 -7,726,138 12,593,048
2017-12-07 2017-12-07 4 IRTC iRhythm Technologies, Inc.
Common Stock
S - Sale -72,000 328,741 -17.97 52.78 -3,800,491 17,352,462
2017-12-07 2017-12-07 4 IRTC iRhythm Technologies, Inc.
Common Stock
S - Sale -6,354 400,741 -1.56 52.15 -331,358 20,898,443
2017-12-07 2017-12-06 4 IRTC iRhythm Technologies, Inc.
Common Stock
S - Sale -14,216 407,095 -3.37 52.29 -743,291 21,285,166
2017-12-07 2017-12-05 4 IRTC iRhythm Technologies, Inc.
Common Stock
S - Sale -57,430 421,311 -12.00 52.41 -3,009,803 22,080,151
2017-11-20 2017-11-17 4 IRTC iRhythm Technologies, Inc.
Common Stock
S - Sale -125,000 478,741 -20.70 52.11 -6,513,775 24,947,289
2017-11-20 2017-11-16 4 IRTC iRhythm Technologies, Inc.
Common Stock
S - Sale -100,000 603,741 -14.21 52.09 -5,208,660 31,446,816
2017-09-15 2017-09-13 4 IRTC iRhythm Technologies, Inc.
Common Stock Warrant (Right to Buy)
X - Other -72,389 0 -100.00
2017-09-15 2017-09-13 4 IRTC iRhythm Technologies, Inc.
Common Stock
S - Sale -34,603 703,741 -4.69 49.51 -1,713,160 34,841,513
2017-09-15 2017-09-13 4 IRTC iRhythm Technologies, Inc.
Common Stock
S - Sale -10 738,344 0.00 45.82 -458 33,833,875
2017-09-15 2017-09-13 4 IRTC iRhythm Technologies, Inc.
Common Stock
X - Other 72,389 738,354 10.87
2017-07-07 2017-04-26 4 IRTC iRhythm Technologies, Inc.
Employee Stock Option (right to buy)
A - Award 3,007 3,007
2017-07-07 2017-04-26 4 IRTC iRhythm Technologies, Inc.
Common Stock
A - Award 1,405 1,405
2017-06-08 2017-06-08 4 IRTC iRhythm Technologies, Inc.
Common Stock
S - Sale -292,000 665,965 -30.48 38.04 -11,107,680 25,333,309
2017-06-08 2017-06-06 4 IRTC iRhythm Technologies, Inc.
Common Stock
S - Sale -138,624 957,965 -12.64 36.63 -5,077,797 35,090,258
2017-05-16 2017-05-16 4 IRTC iRhythm Technologies, Inc.
Common Stock
S - Sale -130,000 1,096,589 -10.60 35.25 -4,582,500 38,654,762
2017-05-16 2017-05-16 4 IRTC iRhythm Technologies, Inc.
Common Stock
S - Sale -80,000 1,226,589 -6.12 36.26 -2,900,800 44,476,117
2017-05-16 2017-05-15 4 IRTC iRhythm Technologies, Inc.
Common Stock
S - Sale -235,000 1,306,589 -15.24 34.25 -8,048,750 44,750,673
2017-05-16 2017-05-12 4 IRTC iRhythm Technologies, Inc.
Common Stock
S - Sale -200,000 1,541,589 -11.48 34.25 -6,850,000 52,799,423
2016-10-25 2016-10-25 4 IRTC iRhythm Technologies, Inc.
Series D Preferred Stock Warrant (Right to Buy)
C - Conversion -72,389 0 -100.00
2016-10-25 2016-10-25 4 IRTC iRhythm Technologies, Inc.
Series E Convertible Preferred Stock
C - Conversion -155,548 0 -100.00
2016-10-25 2016-10-25 4 IRTC iRhythm Technologies, Inc.
Series D Convertible Preferred Stock
C - Conversion -190,154 0 -100.00
2016-10-25 2016-10-25 4 IRTC iRhythm Technologies, Inc.
Series C Convertible Preferred Stock
C - Conversion -610,136 0 -100.00
2016-10-25 2016-10-25 4 IRTC iRhythm Technologies, Inc.
Common Stock
P - Purchase 25,000 1,741,589 1.46 17.00 425,000 29,607,013
2016-10-25 2016-10-25 4 IRTC iRhythm Technologies, Inc.
Common Stock
C - Conversion 1,716,589 1,716,589
2015-03-26 2015-03-24 4 MEIP MEI Pharma, Inc.
Common Stock
S - Sale -1,601,390 0 -100.00 1.97 -3,160,183
2014-12-22 2014-12-18 4 VSAR Versartis, Inc.
Common Stock
S - Sale -150,000 2,409,374 -5.86 19.01 -2,851,845 45,807,741
2014-12-10 2014-12-09 4 MEIP MEI Pharma, Inc.
Common Stock
S - Sale -70,081 1,601,390 -4.19 6.01 -421,082 9,621,952
2014-12-10 2014-12-08 4 MEIP MEI Pharma, Inc.
Common Stock
S - Sale -9,004 1,671,471 -0.54 6.05 -54,495 10,116,244
2014-11-18 2014-11-17 4 DRTX Durata Therapeutics, Inc.
Common Stock
D - Sale to Issuer -3,028,439 0 -100.00
2014-11-13 2014-11-11 4 VSAR Versartis, Inc.
Common Stock
S - Sale -800,000 2,559,374 -23.81 19.37 -15,496,000 49,575,074
2014-10-01 2014-09-29 4 VSAR Versartis, Inc.
Common Stock
S - Sale -12,556 3,359,374 -0.37 20.02 -251,331 67,243,917
2014-03-28 2014-03-27 4 VSAR Versartis, Inc.
Series B Convertible Preferred Stock
C - Conversion -759,565 0 -100.00
2014-03-28 2014-03-27 4 VSAR Versartis, Inc.
Warrant
X - Other -759,565 0 -100.00
2014-03-28 2014-03-27 4 VSAR Versartis, Inc.
Series E Convertible Preferred Stock
C - Conversion -3,546,094 0 -100.00
2014-03-28 2014-03-27 4 VSAR Versartis, Inc.
Series D2 Convertible Preferred Stock
C - Conversion -1,349,433 0 -100.00
2014-03-28 2014-03-27 4 VSAR Versartis, Inc.
Series D1 Convertible Preferred Stock
C - Conversion -3,050,019 0 -100.00
2014-03-28 2014-03-27 4 VSAR Versartis, Inc.
Series C Convertible Preferred Stock
C - Conversion -8,439,620 0 -100.00
2014-03-28 2014-03-27 4 VSAR Versartis, Inc.
Series B Convertible Preferred Stock
C - Conversion -20,942,466 0 -100.00
2014-03-28 2014-03-27 4 VSAR Versartis, Inc.
Common Stock
P - Purchase 60,000 3,371,930 1.81 21.02 1,261,200 70,877,969
2014-03-28 2014-03-27 4 VSAR Versartis, Inc.
Common Stock
C - Conversion 66,049 3,311,930 2.03
2014-03-28 2014-03-27 4 VSAR Versartis, Inc.
Common Stock
C - Conversion 308,356 3,245,881 10.50
2014-03-28 2014-03-27 4 VSAR Versartis, Inc.
Common Stock
C - Conversion 117,342 2,937,525 4.16
2014-03-28 2014-03-27 4 VSAR Versartis, Inc.
Common Stock
C - Conversion 265,219 2,820,183 10.38
2014-03-28 2014-03-27 4 VSAR Versartis, Inc.
Common Stock
C - Conversion 733,880 2,554,964 40.30
2014-03-28 2014-03-27 4 VSAR Versartis, Inc.
Common Stock
C - Conversion 1,821,084 1,821,084
2014-03-20 2014-03-18 4 CMRX CHIMERIX INC
Common Stock
J - Other -700,000 1,543,394 -31.20
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Series C Preferred Stock
C - Conversion 77,522 0 -100.00
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Series B Preferred Stock
C - Conversion 442,478 0 -100.00
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
C - Conversion 13,721 107,327 14.66
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
C - Conversion 78,315 93,606 512.16
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
30,582
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
30,582
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
30,582
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
30,582
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
30,582
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
30,582
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
30,582
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
30,582
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
30,582
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
30,582
2013-11-25 2013-11-21 4 MEIP MEI Pharma, Inc.
Common Stock
S - Sale -365,000 1,680,475 -17.84 8.25 -3,011,250 13,863,919
2013-11-21 3 OXFD Oxford Immunotec Global PLC
Ordinary Shares
1,377,497
2013-11-20 2013-11-20 4 RLYP Relypsa Inc
Warrant to Purchase Common Stock
M - Exercise -25,977 0 -100.00
2013-11-20 2013-11-20 4 RLYP Relypsa Inc
Warrant to Purchase Common Stock
J - Other 25,977 25,977
2013-11-20 2013-11-20 4 RLYP Relypsa Inc
Warrant to Purchase Preferred Stock
J - Other -17,671 0 -100.00
2013-11-20 2013-11-20 4 RLYP Relypsa Inc
Series C-2 Preferred Stock
C - Conversion -125,067 0 -100.00
2013-11-20 2013-11-20 4 RLYP Relypsa Inc
Series C-1 Preferred Stock
C - Conversion -541,960 0 -100.00
2013-11-20 2013-11-20 4 RLYP Relypsa Inc
Series B-2 Preferred Stock
C - Conversion -378,773 0 -100.00
2013-11-20 2013-11-20 4 RLYP Relypsa Inc
Series B-1 Preferred Stock
C - Conversion -259,676 0 -100.00
2013-11-20 2013-11-20 4 RLYP Relypsa Inc
Series A-1 Preferred Stock
C - Conversion -497,093 0 -100.00
2013-11-20 2013-11-20 4 RLYP Relypsa Inc
Common Stock
P - Purchase 185,978 2,114,890 9.64 11.00 2,045,758 23,263,790
2013-11-20 2013-11-20 4 RLYP Relypsa Inc
Common Stock
F - Taxes -21,691 1,928,912 -1.11 11.00 -238,601 21,218,032
2013-11-20 2013-11-20 4 RLYP Relypsa Inc
Common Stock
M - Exercise 25,977 1,950,603 1.35 9.18 238,594 17,915,898
2013-11-20 2013-11-20 4 RLYP Relypsa Inc
Common Stock
C - Conversion 125,067 1,924,626 6.95
2013-11-20 2013-11-20 4 RLYP Relypsa Inc
Common Stock
C - Conversion 541,960 1,799,559 43.09
2013-11-20 2013-11-20 4 RLYP Relypsa Inc
Common Stock
C - Conversion 378,773 1,257,599 43.10
2013-11-20 2013-11-20 4 RLYP Relypsa Inc
Common Stock
C - Conversion 381,733 878,826 76.79
2013-11-20 2013-11-20 4 RLYP Relypsa Inc
Common Stock
C - Conversion 497,093 497,093
2013-05-08 2013-05-08 4 MEIP MEI Pharma, Inc.
Common Stock
S - Sale -100,000 2,045,475 -4.66 8.45 -845,000 17,284,264
2013-05-08 2013-05-06 4 MEIP MEI Pharma, Inc.
Common Stock
S - Sale -100,000 2,145,475 -4.45 8.70 -870,000 18,665,632
2013-04-22 2013-04-19 4 MEIP MEI Pharma, Inc.
Common Stock
S - Sale -157,300 2,245,475 -6.55 8.43 -1,326,039 18,929,354
2013-04-22 2013-04-18 4 MEIP MEI Pharma, Inc.
Common Stock
S - Sale -100,000 2,402,775 -4.00 8.57 -857,000 20,591,782
2013-02-20 2013-02-19 4 MEIP MEI Pharma, Inc.
Common Stock
S - Sale -300,000 2,502,775 -10.70 6.80 -2,040,000 17,018,870
2013-02-20 2013-02-15 4 MEIP MEI Pharma, Inc.
Common Stock
S - Sale -197,225 2,802,775 -6.57 6.60 -1,301,685 18,498,315
2012-12-28 3 MEIP MEI Pharma, Inc.
Common Stock
3,000,000
2012-08-06 2012-08-02 4 WHRT WORLD HEART CORP
Warrants (right to buy)
D - Sale to Issuer -2,341,920 0 -100.00 0.10 -233,021
2012-08-06 2012-08-02 4 WHRT WORLD HEART CORP
Common Stock
D - Sale to Issuer -6,063,603 0 -100.00
2012-07-26 2012-07-24 4 DRTX Durata Therapeutics, Inc.
Series A Preferred Stock
C - Conversion -17,953,008 0 -100.00
2012-07-26 2012-07-24 4 DRTX Durata Therapeutics, Inc.
Common Stock
P - Purchase 784,313 3,028,439 34.95 9.00 7,058,817 27,255,951
2012-07-26 2012-07-24 4 DRTX Durata Therapeutics, Inc.
Common Stock
C - Conversion 2,244,126 2,244,126
2009-02-06 3 TSPT Transcept Pharmaceuticals Inc
Common Stock
1,636,982
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)